Home › Studies › PRJNA1254622
PRJNA1254622 SRP580932

Gut microbiome in rectal cancer patients vs controls

Patients with pelvic irradiation

57 longitudinal gut microbiome samples from adults with locally advanced rectal cancer undergoing total neoadjuvant therapy with pelvic irradiation, compared with healthy controls, examining baseline and on-treatment microbiome markers of treatment response. machine-written summary

57 samples · 57 runs · HU · Adult · 2026 · 6.87 Gbp / sample

Sources
✓Sequence archive 513○Abstract / description–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive513 sample values (collection date, country, health condition, health condition detail, intervention, intervention detail, location locality, subject id)
○ Abstract / descriptionread; no usable statement
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult57
Condition
colorectal_cancer39
healthy_control18
Country
HU57
Body site
primary57
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 57 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 6.87 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

13 of 31 people sampled more than once (39 samples; median 3, up to 3 per person). Schedule stated by the source: “Samples taken at baseline and on-treatment timepoints during total neoadjuvant therapy with pelvic irradiation, keyed by number_of_dose (0,1,2,3) and sample suffixes _1/_2/_3 per patient (e.g., patien” (time origin: intervention/treatment start).

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category57 100%
country57 100%57
health_condition57 100%57
subject_id57 100%57
collection_date57 100%57
detailed_location57 100%
health_condition_detail57 100%57
intervention57 100%57
intervention_detail57 100%57
location_locality57 100%57
timepoint_label57 100%57
Papers (1)
  • Baseline Gut Microbiome Profiling in Therapy-Naive Patients with Locally Advanced Rectal Cancer Identifies Signatures of Response to Total Neoadjuvant Therapy 2026 own_data
Details
Archive description

Total neoadjuvant therapy (TNT) is standard for locally advanced rectal cancer, yet treatment response is biologically heterogeneous, underscoring the need for predictive biomarkers. It is aimed to characterize how baseline and on-treatment gut microbiome ecology relate to clinically relevant response dimensions, and to identify baseline-level markers that could be integrated into a pre-treatment response score.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.72. Assay shotgun_dna.

  • host study.title · “Patients with pelvic irradiation”
  • body site study.description · “baseline and on-treatment gut microbiome ecology”
  • life stage study.description · “locally advanced rectal cancer”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN48116384collection_date2024R10.90biosample.attribute:collection_date2024
SAMN48116384countryHUR10.90sample.attr.geo_loc_nameHungary: Debrecen
SAMN48116384health_conditionhealthy_controlR10.90biosample_attrhealthy
SAMN48116402health_conditioncolorectal_cancerR10.85biosample.attribute:patient_statuspatient_status: disease
SAMN48116384health_condition_detailhealthyR10.90sample.attr.patient_statushealthy
SAMN48116384interventionno_interventionR10.90biosample.attribute:number_of_dosenumber_of_dose: 0_dose
SAMN48116384intervention_detailno treatment doses received (baseline)R10.90biosample.attribute:number_of_dosenumber_of_dose: 0_dose
SAMN48116384location_localityDebrecenR10.85biosample.attribute:geo_loc_nameHungary: Debrecen
SAMN48116384subject_idC1R10.70sample.name_rule:library_namehealthy_C1
SAMN48116384timepoint_label0_doseR10.85biosample.attribute:number_of_dosenumber_of_dose: 0_dose
Sequencing

57 runs over 57 samples · mean 6.96 Gbp per run (median 6.87 Gbp, total 396.99 Gbp; 57 runs with a base count) · layout PAIRED 57 · platform ILLUMINA 57 · models Illumina NovaSeq 6000 (57) · 0% of runs with a Sandpiper profile · first public 2026-06-17

Authors (0)

No author record.

Downloads

PRJNA1254622.csv.gz (2.4 KB) · parquet (72.1 KB) — all 57 samples, every field with route and confidence · PRJNA1254622_determinations.csv.gz (4.3 KB) — 513 evidence rows

Samples (57 · every field this project has values for · hover a cell for its source)
Loading the sample table…